Natco Pharma consolidated Q1FY23 PAT jumps to Rs. 320.4 Cr

Natco Pharma consolidated Q1FY23 PAT jumps to Rs. 320.4 Cr

By: IPP Bureau

Last updated : August 10, 2022 12:23 pm



The company has reported total income of Rs. 918.9 crores during the period ended June 30, 2022.


Natco Pharma Limited has posted net profit of Rs. 320.4 crores for the period ended June 30, 2022 as against net loss of Rs. 50.5 crores for the period ended March 31, 2022. The company posted net profit of Rs.75 crores for the period ended June 30, 2021.

The company has reported total income of Rs. 918.9 crores during the period ended June 30, 2022 as compared to Rs. 610.6 crores during the period ended March 31, 2022. It reported total income of Rs.427.3 crores during the period ended June 30, 2021.

 

Natco Pharma Limited

First Published : August 10, 2022 12:00 am